Q4FY17 Results: Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Ltd. reported its results for the quarter ended March 31, 2017 today.

The company's total sales for Q4FY17 came in at Rs 736.5 crore, which represents a 4.33 per cent sequential decline and 18.96 per cent YoY increase.

Its operating profit (EBIT) for the quarter was Rs 111.44 crore and its EBIT margin stood at 15.13 per cent.

The company reported PAT of Rs 95.33 crore, which represents a sequential QoQ increase of 12.96 per cent and a YoY increase of 4.44 per cent.

The company's stock opened for trading at Rs 619 on the BSE and declined 1.62 per cent to close at Rs.609.
 
Alembic Pharmaceuticals Ltd is an India-based integrated pharmaceutical company. The company’s business is divided into the following segments: active pharmaceutical ingredients, bulk pharma chemicals, formulations, herbal nutraceuticals, veterinary and contract/collaborated research services.